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Abstract
Background: Phosphoantigen was originally identified as the main cd TCR-recognized antigen that could activate cd T cells
to promote immune protection against mycobacterial infection. However, new evidence shows that the cd T cells activated
by phosphoantigen can only provide partial immune protection against mycobacterial infection. In contrast, whole lysates
of Mycobacterium could activate immune protection more potently, implying that other cd TCR-recognized antigens that
elicit protective immune responses. To date, only a few distinct mycobacterial antigens recognized by the cd TCR have been
characterized.
Methodology/Principal Findings: In the present study, we established a new approach to screen epitopes or protein
antigens recognized by the cd TCR using Bacillus Calmette-Gue ´rin- (BCG-) specific cd . TCR transfected cells as probes to pan
a 12-mer random-peptide phage-displayed library. Through binding assays and functional analysis, we identified a peptide
(BP3) that not only binds to the BCG-specific cd TCR but also effectively activates cd T cells isolated from human subjects
inoculated with BCG. Importantly, the cd T cells activated by peptide BP3 had a cytotoxic effect on THP-1 cells infected with
BCG. Moreover, the oxidative stress response regulatory protein (OXYS), a BCG protein that matches perfectly with peptide
BP3 according to bioinformatics analysis, was confirmed as a ligand for the cd TCR and was found to activate cd T cells from
human subjects inoculated with BCG.
Conclusions/Significance: In conclusion, our study provides a novel strategy to identify epitopes or protein antigens for the
cd TCR, and provides a potential means to screen mycobacterial vaccines or candidates for adjuvant.
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Introduction
Approximately 2 billion people worldwide are infected with M.
tuberculosis and around 3 million deaths occur annually due to this
disease. Several immune protective mechanisms are involved in
controlling the infection of M. tuberculosis including cytokine release
and effector functions of immune cells. cd . T cells, a subset of
immune cells, play important roles in host immunity as a bridge
between innate and adaptive immunity. In recent years, increasing
amounts of research have concentrated on the immune protective
function of cd T cells in M. tuberculosis infection [1–4]. However,
the mechanisms by which cd T cells recognize tuberculosis
antigens remain unclear and little is known about the distinct
tuberculosis protein antigens that can effectively activate cd . T
cells.
cd . T cells recognize a variety of antigens. The best-known
antigens for cd . T cells are phosphoantigens, such as pyropho-
sphoantigen, aminobisphonate, and alkylamine [5–6]. With the
progress of research in cd T cells, additional protein antigens
recognized by cd T cells are being identified continually. MHC
class I chain-related gene A (MICA) and B (MICB) were
recognized by Vd1 cd . T cells [7]. UL-16 binding protein 4
(ULBP4) was shown to be a novel ligand for c9/d2 T cells [8]. The
results of Chen et al. [9] suggested that human mutS homolog 2
(hMSH2) might be a new ligand for the cd TCR. Moreover, other
protein antigens, such as ectopically expressed mitochondrial
ATPase [10], were identified as ligands for the cd TCR.
cd T cells recognize M. tuberculosis antigen and promote
immune-protection against mycobacterial infection. Originally,
phosphoantigen was regarded as the main cd TCR-recognized
antigen that activated cd T cells. However, phosphoantigen-
activated cd T cells display a restricted TCR diversity and only a
subset of phosphoantigen-responsive cd T cells mediate protective
immunity against tuberculosis [11]. In contrast, whole lysates of
Mycobacterium activate immune protection more potently, implying
that other cd TCR-recognized antigens in Mycobacterium also elicit
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antigens with a molecular mass of 10–14 kDa in the supernatant
from heat-treated Mycobacterium functioned as bioactivators that
stimulated cd T cells [12]. The protein antigens of M. tuberculosis
effectively activated cd T cells, which in turn induced innate and
adaptive immunity to M. tuberculosis. At the same time, cd . T cells
participated in the anti-tuberculosis immune response elicited by
other immune cells [13–16]. The interaction net composed of
many types of immune cells plays an important role in the control
of M tuberculosis. However, up to now, ESAT-6 [17] is the only
tuberculosis protein antigens identified to be recognized by cd
TCR.
Recently, a novel strategy that used intact cells as probes to pan
target peptides in a phage-display library was developed [18–19].
Using the hepatocellular carcinoma cell line HepG2 as a probe,
Zhang et al. obtained a target peptide HCBP1 that may be a
potential candidate for targeted drug therapy for liver cancer [20].
To identify mycobacterial antigen, Alderson et al. developed a
technique using Mycobacterium-specific CD4
+ T cells to screen a
mycobacterial genomic library. The direct identification of
antigens using T cells would undoubtedly be critical to detect
unknown antigens in Mycobacterium [21]. Their research inspired us
to develop a novel strategy to screen a phage-display library using
cd T cells cultured in vitro. To obtain cd T cells purely by in vivo
culture was infeasible due to the difficulty in culturing these cells
and the limited quantity of cd T cells. We addressed these
problems by transfecting cells with specific cd TCR. After the full-
length c chain and d chain were co-transfected to J.RT3-T3.5
cells, a T-lymphoma cell line deficient in both TCR a/c and b/d
chains (ATCC), the transfected cells with homogeneous cd TCR
were used as cd T cells to analyze the recognition mechanism of
cd TCR to antigens [8,22,23,24] and to identify the antigens
recognized by cd T cells [8]. In addition, while the antigen binding
site of the cd TCR is primarily formed from 3 CDRs contributed
by each Vc or Vd domain, the sequence diversity in antigen
receptors is highly concentrated in 1 or 2 CDR3s [9]. Based on
known CDR3 sequences of cd T cells, we generated cell lines
expressing specific cd TCR, which may be used as a probe to pan
antigen peptides recognized by cd TCR.
In this study, the BCG-specific cd TCR-expressing cell lines
(tester) and non-specific cd TCR (driver) were used to carry out
subtractive screening in vitro with a phage display 12-mer peptide
library. After 4 rounds of panning, there was an obvious
enrichment for the phages specifically binding to the cd TCR. A
group of peptides capable of specifically binding to the cd TCR
was obtained. After functional tests and bioinformatics analyses,
we identified a target peptide (BP3) that could be recognized by
the cd TCR and activate cd T cells from human subjects
inoculated with BCG. Importantly, we demonstrate that oxidative
stress response regulatory protein (OXYS) that contains the
identified peptide could be recognized by cd TCR and activate cd
T cells from human subjects inoculated with BCG.
Results
Construction of the transfected cells expressing BCG
specific cd . TCR (BCG cd T cells) and BCG non-specific cd
TCR (DBS4.3 cd T cells)
As reported by Spencer [11], the dominant BCG specific c9
CDR3 sequence in human is LWEVISELGKKIK and d2 CDR3
is ACDTVGSYVPTGETDKL. Accordingly, we designed the
overlapping forward and reverse primer (supporting information
table S1) containing the nucleic acid sequences encoding the above
peptides to substitute the original CDR3 region by using
overlapping PCR. The PCR products of the full-length c9 and
d2 chains are shown in Figure 1B. These PCR fragments were
then cloned into pREP7 and pREP9 expression vectors and co-
transfected into J.RT3-T3.5 cells by electroporation. After
selection and FACS analysis, ,40% of the transfected cells were
shown to express the c9/d2 TCR (Figure 1C). We chose a known
human cd T cell clone, DBS4.3 cd T cells to be the BCG non-
specific cd TCR control. The c9 and d2 CDR3 sequences of
DBS4.3 are LWEWELGKKIK and ACDTLVSTDKL [26],
respectively (Figure 1A). The cells expressing DBS4.3 cd TCR
were constructed using a similar procedure. Forty percent of the
cells expressed the c9/d2 TCR. The transfected cells were
enriched by flow sorting (Figure 1C). To check the BCG specificity
of the transfected cd TCR, the cells expressing BCG-specific and
non-specific cd TCR were stimulated with protein extracts of
BCG and the level of secreted IL-2 was measured by ELISA. As
shown in Figure 1D, the protein extract of BCG stimulated the
BCG-specific cd T cells and induced much more IL-2 than the
DBS4.3 cd T cells, suggesting that J.RT3-T3.5 transfected cells
expressing BCG-specific cd TCR were successfully generated.
Biopanning of BCG cd . TCR recognized peptides from
phage library using the transfected cells
To identify the epitopes recognized by BCG-specific cd . TCR,
we performed a cd TCR cell-mediated biopanning of a 12-mer
random peptide phage-display library. The experimental proce-
dure is shown in Figure 2A. Phages specifically binding to BCG-
specific cd TCR were identified through 4 rounds of in vitro
panning. After 4 rounds of in vitro selection and enrichment, the
number of eluted phages increased 4000 fold (from 5.8610
4 pfu to
2.4610
8 pfu) compared to that of the phages in the first round
(Table 1). The output/input ratio of phages after each round of
panning was used to determine the phage recovery efficiency and
an obvious enrichment of phages specifically binding to BCG cd T
cells was found (Table 1). By analyzing the results of phage-ELISA
(Figure 2B), 30 phage clones specifically binding to the BCG-
specific cd T cells (the ratio of specific binding to nonspecific
binding was more than 2) were amplified by RT-PCR (Figure 2C).
The RT-PCR products were sequenced using the specific
sequencing primer provided from the kit and the results are
shown in Table 2. Three prominent peptides were selected as
candidates for further functional study based on their high
frequency of appearance among the 30 sequences. These three
peptides were designated as BP1, BP2, and BP3 respectively and
then chemically synthesized for further use.
Confirmation of peptide binding to the BCG specific cd
TCR transfected cells
Binding assays and blocking assays were performed to
determine whether the synthesized peptides specifically bind to
BCG-specific cd TCR, using ELISA and FACS. We first
examined IL-2 production after the transfected cells were
stimulated by the 3 putative peptides. All 3 peptides could
stimulate BCG-specific cd T cells to secrete IL-2 in a dose-
dependent manner. Importantly, the IL-2 production of the BCG-
specific cd T cells stimulated by BP3 could be significantly blocked
by functional cd TCR blocking monoclonal antibody at some
dosages, suggesting that the binding between BP3 and the BCG-
specific cd TCR transfected cells was specific (Figure 3A). The
binding of transfected cells with peptides was further confirmed by
FACS analysis. Although BP1, BP2, and BP3 all bound to BCG-
specific cd T cells, only the binding of BP3 could be blocked by
functional cd TCR blocking monoclonal antibody (Figure 3B).
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specifically bound to BCG-specific cd T cells.
Binding and activation of cd T cells from human subjects
inoculated with BCG by epitope peptides in vitro
Since BP3 could specifically bind the BCG-specific cd T cells,
we infer it might contain a cd TCR recognized epitope. A binding
assay and amplification assay were performed, using PBMC
isolated from human subjects inoculated with BCG or un-
inoculated subjects, to investigate whether natural cd T cells
could recognize and become activated by the epitope peptide.
Fresh PBMC were immobilized with anti-pan cd TCR monoclo-
nal antibody in 24-well culture plates with RPMI 1640 medium
for 2 weeks to obtain enough numbers of cd T cells. Flow
cytometry was performed to analyze the binding capability of
biotinylated BP3 with enriched cd T cells from BCG vaccinated
subjects and un-vaccinated subjects. Thirty-three percent of cd T
cells from human subjects inoculated with BCG bound to BP3;
whereas only 5% cd T cells from human subjects un-inoculated
with BCG bound to BP3 (Figure 4A). In addition, immobilized
BP3 were able to induce expansion of cd T cells in PBMC from
human subjects inoculated with BCG to an average 18% after co-
culture for 2 weeks, significantly higher than the expansion to 6%
cd T cells in PBMC from human subjects un-inoculated with BCG
(Figure 4B). The proliferation of cd T cells expanded by BP3
peptide was further confirmed by the CCK-8 assay (Figure 4C).
Taken together, these data demonstrate that the candidate epitope
BP3 could bind and activate cd T cells from human subjects
inoculated with BCG in vitro.
The immune functions of cd . T cells from human subjects
inoculated with BCG induced by peptide BP3
We determined the immune functions of cd T cells from human
subjects inoculated with BCG induced by peptide BP3 using
cytokine production and cytotoxicity assays. A strong enhancing
effect on Th1 cytokine (IFN-c and TNF-a) production, but not
Th2 cytokine (IL-4 and IL-10) production, was observed in cd T
cells from subjects inoculated with BCG and expanded by BP3
(Figure 5A). Then, we examined the cytotoxicity of cd T cells
induced by peptide to THP-1 cells infected by BCG. cd T cells
induced by peptide BP3 had a cytotoxic effect on THP-1 cells
infected by BCG (Figure 5B).
BLAST analysis
BLAST search was performed to identify motif-containing
mycobacterial proteins in the sequences of 3 peptides. BLAST
Figure 1. Construction of the transfected cells expressing BCG specific cd TCR and DBS 4.3 cd TCR. (A) The prominent c9 and d2 CDR3
sequence of BCG specific cd TCR and DBS4.3 cd TCR in human. (B) Construction of full-length c9 and d2 chain with BCG specific CDR3 sequence and
DBS4.3 cd TCR by overlapping PCR. Lane 1 and lane 7. The PCR product amplified by using c9 upstream primer and overlapping reverse primer; Lane
2 and lane 8. The PCR product amplified by using overlapping forward primer and c9 downstream primer; Lane 3 and lane 9. The full-length c9 chain
containing prominent BCG specific CDR3 sequence or DBS4.3 CDR3 sequence amplified by using above PCR products as the template and c9
upstream and downstream primer as the primers; Lane 4 and lane 10. The PCR product amplified by using d2 upstream primer and overlapping
reverse primer; Lane 5 and lane 11. The PCR product amplified by using overlapping forward primer and d2 downstream primer; Lane 6 and lane 12.
The full-length of d2 chain with prominent BCG specific CDR3 sequence or DBS4.3 CDR3 sequence amplified by using above PCR products as the
template and d2 upstream and downstream primer as the primers. (C) Assessment of cd TCR expressed on J.RT3-T3.5 transfected cells via FACS
analysis. Cells were stained with PE-anti c9 monoclonal antibody and FITC-anti d2 TCR monoclonal antibody. Panel 1 and panel 3 were the transfected
cells expressing BCG specific cd TCR before and after flow sorting, respectively. Panel 2 and panel 4 were the transfected cells expressing DBS4.3 cd .
TCR before and after flow sorting, respectively. (D) IL-2 secretion of the BCG specific cd TCR and DBS 4.3 cd TCR stimulated with whole protein
extracts of BCG were measured by ELISA. The double asterisks denote significant difference (p,0.01). Data are shown as the mean of pg/ml6S. D. of
three independent experiments.
doi:10.1371/journal.pone.0018809.g001
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matching characteristics to protein in Mycobacterium, with an E
value of 39.2. The matching protein of BP3 was oxidative stress
response regulatory protein (OXYS) in M. tuberculosis K85, M.
tuberculosis CPHL_A and LysR family of transcriptional regulator in
M. tuberculosis KZN 4207. Moreover, another BLAST analysis in all
species demonstrated that there were no significant matches with
other proteins. Meanwhile, further BLAST analyses confirmed
that OXYS protein also exists in M. bovis BCG str. Pasteur 1173P2.
It is conserved in BCG and many mycobacteria. Combining the
above experimental results and bioinformatics analyses, the BP3
peptide was regarded as a promising candidate epitope peptide,
which was recognized by the cd TCR. In addition, OXYS protein
was regarded as a candidate antigen recognized by the cd TCR
and selected for further analysis.
The OXYS protein binds and activates cd T cells in vitro
To date, there have been some controversies about whether cd
T cells could recognize intact protein, the recognition mechanism
of cd T cells to antigen remains uncertain. Although our study
demonstrated BP3 could bind and activate cd T cells, we had not
yet determined whether its matched protein could be recognized
by cd T cells. To answer this question, we examined the binding
activity of OXYS protein to transfected cd T cells, as well as its
ability to activate natural cd T cells. We expressed the full-length
OYXS protein with His tag in E. coli. The purification of OXYS
protein was determined by SDS-PAGE (Figure 6A) and western
blot with anti-His tag mAb (Figure 6B). The IL-2 secretion from
BCG-specific cd T cells and DBS4.3 cd T cells after stimulation
with purified OXYS protein at different concentrations was
examined. Production of IL-2 in BCG-specific cd T cells increased
in a dose-dependent manner after simulation with OXYS protein
(Figure 6C). Furthermore, exposure to OXYS protein induced
expansion of cd T cells in PBMC from human subjects inoculated
with BCG to an average of 16% after co-culture for 2 weeks,
significantly higher than the 6% cd T cells in PBMC from human
subjects un-inoculated with BCG (Figure 6D). The proliferation of
cd T cells expanded by OXYS protein was confirmed by the
Figure 2. Biopanning of BCG specific cd TCR recognized peptides from phage library using the transfected cells. (A) The flow chart
about screening and analysis of the peptides recognized by BCG specific cd TCR. (B) Selection of BCG specific cd TCR recognized positive phage
clones by phage-ELISA. Representative data are shown in this figure. Dark arrow pointed bars represent the ratio of specific binding to nonspecific
binding was more than 2, and corresponding phage clones were taken as positive clones. (C) Confirmation of BCG specific cd TCR recognized positive
clones by RT-PCR. The BCG specific cd TCR recognized peptides were rescued by RT-PCR using phage specific primer provided in kit. 9 individual
representative clones are shown in this figure. The RT-PCR products of positive clones were sequenced using specific sequencing primer.
doi:10.1371/journal.pone.0018809.g002
Table 1. Output Assay for Each Round of Plaque Selection.
Round of bio-panning Phages inputted(PFU*) Phages eluted(PFU) Yield**
1st 1.5610
11 5.8610
4 3.8610
27
2nd 2.5610
11 2.8610
6 1.1610
25
3rd 3.0610
11 2.2610
8 7.3610
24
4th 2.0610
11 2.4610
8 1.2610
23
*PFU:Plaque forming unit.
**Yield=phages eluted/phages inputted.
doi:10.1371/journal.pone.0018809.t001
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protein expressed in E. coli could specifically bind to the cd TCR,
and activate cd T cells from human subjects inoculated with BCG,
suggesting cd TCR might recognize intact protein as antigens.
Discussion
In this study, we developed a novel strategy to identify epitopes
and protein antigens recognized by cd T cells by combining
immunological and biochemical methods. With this strategy, we
identified a promising cd T cell-reactive BCG-specific epitope
(peptide BP3) and one candidate BCG protein recognized by cd T
cells (protein OXYS). BCG-specific cd TCR transfected cells
could bind the peptide and could stimulate the expansion of cd T
cells from human subjects inoculated with BCG. Moreover, the
BP3 matched mycobacterial protein OXYS was also bound by the
BCG-specific cd TCR transfected cells and in vitro, activated the cd
T cells from human subjects inoculated with BCG.
Previously, the cd TCR transfected cells were used to evaluate
the roles of some amino acids in antigen recognition [24–28]. This
system could also be used to screen the antigens recognized by cd
T cells. Kong et al. [8] identified a cd TCR recognized protein
ULBP4 using the specific cd TCR transfected cells. In our study,
we first applied the transfected cells as probes to pan the phage
library for screening of the epitopes recognized by cd TCR. Prior
to the panning process, we constructed the BCG-specific cd TCR-
transfected cells as tester cells and non-specific cd TCR-
transfected cells as driver cells. We performed 4 rounds of in vitro
subtractive panning on tester and driver cells and developed some
optimizing procedures to improve the probability of obtaining
specific phages with high affinity. The binding specificity of BP3
and OXYS to the cd TCR and their ability to activate transfected
cell lines and natural cd T cells proved the success of this method.
The new method can be used to detect additional protein antigens
recognized by cd T cells in the future.
A potential problem of our research is the representativeness of
the CDR3 sequences we used. The CDR3 sequences in BCG-
expanded c9/d2 cells were obtained according to Spencer’s report
[11]. About 60% of the BCG-expanded c9/d2 cells contained the
CDR3 sequence. Thus, the identified epitopes and proteins using
cells transfected with this CDR3 sequence as a probe were specific
to this subset of c9/d2 cells. However, due to the diversity of
CDR3 sequences, the reported CDR3 sequence might not be the
dominant sequence in different areas, people, or races. Therefore,
the CDR3 sequence applied in our study might not be
representative for all c9/d2 cells from human subjects inoculated
with BCG, and the epitopes and proteins determined by this
screening method might not fully represent antigens recognized by
cd T cells from human subjects inoculated with BCG. That might
be the reason why peptide BP1 and BP2 could neither specifically
bind to the transfected cell line expressing BCG-specific cd TCR
(Figure 3B), nor effectively activate cd T cells isolated from human
subjects inoculated with BCG (data not shown), even though they
have a higher frequency of occurrence (Table 2).
As shown in figure 3A, all 3 peptides could stimulate more IL-2
production by DBS4.3 cd T cells than control peptides. We
believe it depends on the difference of DBS4.3 cd TCR and BCG
cd TCR. Both TCRs differ only in the CDR3 sequence. They
have common CDR1, CDR2, and fragment regions. Therefore,
during the screening procedure, we did not guarantee that all
peptides that partially bind driver cells and tester cells could be
excluded. Although BP1, BP2, and BP3 could bind to BCG-
specific cd T cells and DBS4.3 cd T cells, only the binding of BP3
to cells could be blocked by a functional cd TCR blocking
monoclonal antibody.
In this study, we identified one epitope peptide recognized by
BCG-specific cd TCR by screening the phD 12 phage-display
peptide-library, but more peptide candidates probably remain
unidentified. The phD 12 phage-display peptide-library was based
on a combinatorial library of random peptide 12-mers fused to a
minor coat protein of M13. The library contained a complexity of
2.7610
9 individual clones, representing the entire obtainable
repertoire of 12-mer peptide sequences, which expresses a random
12 amino acid sequence. However, it still might not fully cover the
sequence of BCG or Mycobacterium. More epitopes for the BCG-
specific cd TCR may be identified by screening the random
expression genomic library of Mycobacterium.
The OXY protein identified as a cd TCR recognized antigen
according to this strategy, is a protein with a molecular mass of
44 kDa. This differs from the results of Boom, who found that
protein antigens with a molecular mass of 10–14 kDa in the
supernatant from Mycobacterium tubercolosis were a major stimulus
for human cd T cells [12]. However, the results of Boom did not
exclude the possibility that other molecular mass of proteins may
have an activation function for cd T cells as well. According to our
strategy, a distinct cd T cell-recognized antigen was identified.
Therefore, different screening methods may be complementary to
each other to explore new protein antigens recognized by the cd
TCR.
We compared cd T cells expanded by BP3 peptide or OXYS
protein obtained from un-vaccinated persons and BCG vaccinated
persons. The results showed that immobilized BP3 was able to
induce the expansion of cd T cells in PBMC from human subjects
inoculated with BCG to an average 18%, significantly higher than
the 6% expansion of cd T cells in PBMC from human subjects un-
inoculatedwithBCG.Meanwhile,OXYSproteinwasabletoinduce
expansion of cd T cells in PBMC from human subjects inoculated
with BCG to an average 16%, significantly higher than the 6%
expansion of cd T cells in PBMC from human subjects un-
inoculated with BCG. In addition to assessing the proliferation of cd
T cells by percentages, we also used the CCK-8 assay to detect the
proliferation of cd T cells. Cell Counting Kit-8 allows sensitive
colorimetric assays for the determination of the number of viable
cells incellproliferation and cytotoxicityassays. CCK-8 was reduced
by dehydrogenases in cells to give a yellow colored product
(formazan), which is soluble in the tissue culture medium. The
amount of the formazan dye generated by the activity of
Table 2. The Amino Acid Sequences of 12 mer Peptides
Screened from the Phage Library.
Phage clones Name Sequence Frequency
12/14/19/20/21/24/27/28/30 BP1 VSRHQSWHPHDL 9/30
4/10/17/26/29 BP2 KPLSKELTLPLQ 5/30
2/8/13/15/16 BP3 HPETQDSDDVDR 5/30
23/25 BP4 ALQLDPTPGPLR 2/30
18/22 BP5 VQPPPKSILGVA 2/30
6/7 BP6 HKLPVTMVLDRA 2/30
11 BP7 SHVDDIQRIPSS 1/30
5 BP8 TSAHGVPIHDYG 1/30
9 BP9 YTPQLLSETSYF 1/30
1 BP10 NFCSYQTYGHIT 1/30
3 BP11 GHTYRPTPSSLL 1/30
doi:10.1371/journal.pone.0018809.t002
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living cells. So according to the change of the absorbance, the data
did show the proliferation of BP3 and OXYS stimulated cd Tc e l l s .
In conclusion, our results provide new insights about cd T cells
and BCG antigen from 3 aspects. First, we provided a novel
strategy to identify epitopes and proteins recognized by cd TCR.
The new strategy could be expanded to the use of detecting other
protein antigens recognized by cd T cells. Second, our findings
added to the understanding of the recognition mechanism of cd
TCR to protein antigens. Third, the peptide BP3 or OXYS
protein were identified as potential candidate peptides or antigenic
components to develop new tuberculosis vaccines or adjuvant, as
well as biomarkers of tuberculosis infection. Further studies are in
progress to confirm the bio-function of the target peptide and
OXYS protein in anti-tuberculosis infection.
Materials and Methods
Ethics Statement
This work received approval from the Clinical Ethics Commit-
tee of the Institute of Pathogen Biology, Chinese Academy of
Medical Sciences and Peking Union Medical College. All subjects
gave their informed consent to participate. The consent was
verbal. The ethics committee specifically approved that procedure.
Subjects
Twenty volunteers composed of 12 men and 8 women aged 15
to 32 years were enrolled in this study. Of these, 15 subjects were
vaccinated with BCG and 5 subjects were not vaccinated with
BCG. Exclusion criteria for all subjects were smoking, medication,
pregnancy and any abnormalities in renal and liver function tests.
Figure 3. Confirmation of the peptide specifically binding to the BCG cd TCR transfected cells. (A) Peptide binding and blocking assay by
detecting the production of IL-2. The DBS4.3 cd T cells, BCG cd T cells and BCG cd T cells blocked with functional cd TCR blocking monoclonal
antibody were stimulated by correspondent epitopic peptides at different concentration, secreted IL-2 was detected by ELISA. Data are shown as the
mean of pg/ml6S.D. of three independent experiments. The single asterisk denote significant difference (p,0.05). (B) Peptide binding and blocking
assay by FACS. The binding percentage of BCG cd T cells or pre-blocked cells by functional cd TCR blocking monoclonal antibody with biotinylated
peptides was evaluated by FACS. The biotinylated peptides were co-cultured with BCG cd T cells or pre-blocked cells by functional cd TCR blocking
monoclonal antibody at 4uC for 1 hour. FITC-coupled streptavidin was added. FACS assay were performed to detect the binding percentage of those
cd T cells with peptides. Panel 1 was the binding percentage of control peptide and three peptides with BCG cd T cells. Panel 2, panel 3 and panel 4
were the binding percentage of BP1, BP2 and BP3 with BCG cd T cells or pre-blocked BCG cd T cells, respectively.
doi:10.1371/journal.pone.0018809.g003
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The phD 12 phage-display peptide-library kit (New England
Biolabs, USA) was used to screen specific peptides binding to cd
TCR. The titer of the library is 2610
13 pfu. The E. coli host strain
ER2738 was used for M13 phage propagation. J.RT3-T3.5 cells
and THP-1 cells, a human myelomonocytic cell line, were
obtained from the American Type Culture Collection (ATCC).
These cells and the transfected cells derived from them were
maintained in RPMI-1640 supplemented with 10% FCS,
penicillin, streptomycin, and 5610
25 M b-mercaptoethanol. cd
T cells were obtained from fresh peripheral blood mononuclear
cells (PBMC) by immobilization by anti-pan-cd TCR monoclonal
antibody (Immunotech). In brief, PBMC was separated from
peripheral blood by density gradient centrifugation on Ficoll-
Hypaque (GE Healthcare). The cells were grown in RPMI 1640
medium supplemented with 12% FCS, 200 U/mL IL-2, penicil-
lin, streptomycin, and 5610
25 M b-mercaptoethanol, in a 24-well
cell culture plate containing immobilized anti-pan-cd TCR
monoclonal antibody at 37uCi n5 %C O 2. Every 3–4 days, half
of the medium was discarded and replenished by fresh medium
and cytokines. After 2 weeks of culture, the viability of cells
assessed by flow cytometry using 7AAD stain was more than 90%.
The purified cell population contained about 80% viable cd T
cells.
Construction of transfected cells expressing BCG-specific
and non-specific cd . TCRs
A full-length c9o rd2 chain was amplified from PBMC cDNA
using specific primers containing KpnIa n dXhoI restriction sites.
The BCG-specific CDR3 sequence was inserted into full-length
c9 and d2 chain to substitute for the original CDR3 sequence
using overlapping PCR. The full-length TCR chain with BCG-
specific CDR3 sequence was digested with KpnIa n dXhoI and
cloned into pREP7 and pREP9 expression vectors with either
hygromycin or neomycin resistance. Meanwhile, full-length
pREP7-c9 and pREP9-d2c h a i n so fD B S 4 . 3 ,ak n o w ncd T-cell
clone, with a different c9a n dd2 CDR3 sequence than the BCG-
specific cd TCR, was also constructed according to same
procedure, as a non-BCG specific control. The J.RT3-T3.5 cells
(1.2610
7) were co-transfected with 20 mgo fp R E P 7 - c9 and
pREP9-d2 by electroporation at 260 V and 975 mF using Bio-
Rad Gene-Pulser. After 48 h, the transfected cells were cultured
in selection medium with hygromycin and neomycin for 4 weeks.
The resulting cells expressing surface cd TCR were evaluated by
flow cytometry with fluorescein isothiocyanate (FITC)-conjugated
anti-human c9 Biolegend and phycoerythrin (PE)-conjugated
anti-human d2 (Biolegend) monoclonal antibody. The double
positive cells were isolated by flow sorting for further experiments
(BD FACSAria I).
Figure 4. Binding and activating cd T cells from BCG vaccinated and BCG un-vaccinated persons by epitope peptides in vitro. (A) BP3
could bind cd T cells from human subjects inoculated with BCG in vitro. Fresh PBMC from BCG vaccinated and BCG un-vaccinated persons in 24-well
culture plates with RPMI 1640 medium were immobilized with anti-pan cd TCR monoclonal antibody for two weeks to obtain enough amounts of cd
T cells. The cells incubated with biotin-conjugated peptide or control peptide and FITC-conjugated streptavidin, and then subjected to FACS analysis.
Results are representative of three independent experiments. (B) The immobilized BP3 was able to induce expansion of cd T cells from human
subjects inoculated by BCG. PBMC from BCG vaccinated and BCG un-vaccinated persons were cultured in 24-well plates with immobilized BP3 and
control peptide in RPMI 1640 medium with 10% FCS and IL-2 (200units/ml). The percentage of cd T cells was measured 2 weeks later by FACS. Results
are representative of three independent experiments. Panel 1 and panel 2 was the proliferation percentage of cd T cells from human subjects un-
inoculated with BCG and inoculated with BCG induced by control peptide, respectively. Panel 3 and panel 4 was the proliferation percentage of cd T
cells from human subjects un-inoculated with BCG and inoculated with BCG induced by BP3, respectively. (C) Detection of cd T cell proliferation by
CCK-8 assay. After the cd T cells expanded by peptide were isolated by flow sorting, they (1610
5/100 ml) were inoculated into a 96-well plate
immobilized with different dosage of peptide and incubated for 4 hours. CCK-8 reagent (10 ml) was added to each pore and continued to culture for
4 hours until the media turned yellow. The absorbance value (450 nm) of each pore was measured using a microplate reader. Data are shown as the
mean of three independent experiments.
doi:10.1371/journal.pone.0018809.g004
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The transfected cells expressing BCG-specific cd TCR (named
BCG cd T cells) were used as tester cells, and the transfected cells
expressing DBS4.3 cd TCR (named DBS4.3 cd T cells) were used
as the driver cells for subtractive screening from a phage-display
12-peptide library. The driver cells were washed with phosphate
buffered saline (PBS) and kept in serum-free RPMI-1640 for 1 h
before blocking with 3 mL blocking buffer (5% bovine serum
albumin (BSA) in PBS) for 30 min at 37uC. Approximately
2610
11 pfu phages were added to the blocked driver cells and
mixed gently for 1 h at 37uC. The cells were then pelleted by
centrifugation at 800 rpm for 5 min. The supernatants containing
the phages were incubated with the blocked tester cells for 1 h at
37uC before the cells were pelleted again. The cells were washed
twice with 0.1% TBST (50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 0.1% Tween-20) to remove unbound phage particles. The
tester cells and bound phages were both incubated with E. coli host
strain ER2738 and the phages were rescued by infection with
bacteria when the cells died. The phage titer was subsequently
evaluated by a blue plaque-forming assay on agar plates
containing tetracycline. Finally, a portion of purified phage
preparation was used as the input phage for the next round of in
vitro selection. In total, 4 rounds of selection were taken. For each
round of selection, 2610
11 pfu of collected phages were used. The
panning intensity was increased by prolonging the phages
incubation process with driver cells to 1.25 h, 1.5 h, and 2 h
and by shortening the process with tester cells to 45 min, 30 min,
and 15 min in the second, third, and fourth rounds of selection,
respectively. Meanwhile the number of TBST washes was
increased to 4, 6, and 8 times in the second, third, and fourth
rounds of selection, respectively.
Identification for phage clones binding to transfected
cells by phage-ELISA, PCR and sequencing
The tester cells and driver cells were seeded into 96-well plates
(1610
5 cells/well) one day before use and then fixed in 96-well
plates, with 4% formaldehyde for 15 min at room temperature.
The plates were washed 3 times with PBS. The amplified phage
clones were then picked out randomly and blocked individually
with 1% BSA at 37uC for 30 min. These phage clones were added
into the tester and driver cells (1610
10 pfu/well) and incubated at
37uC for 2 h. The plates were washed 3 times with PBS, and then
the mouse anti-M13 phage antibody was added at a dilution of
1:1000 in TBST and incubated at 37uC for 1 h. After reaction
with HRP-conjugated goat anti-mouse IgG antibody (eBioscience)
and substrate (Sigma), the plates were read on a microplate reader
(SpectraMax M5) at 450 nm. As negative controls, PBS and
unrelated phages with the same titer were used. The positive
phage clones in ELISA were amplified by PCR, and the parts
containing epitopes were sequenced using the 3730 sequencer with
Figure 5. The immune function of cd T cells from human
subjects inoculated with BCG induced by peptide BP3. (A) The
Th1 and Th2 cytokine production of cd T cells induced by peptide BP3.
After sorting the cd T cells from human subjects inoculated induced by
BP3, the Th1 (IFN-c and TNF-a) and Th2 (IL-4 and IL-10) type cytokine
production was detected by ELISA kit. Data are shown as the mean of
pg/ml6S.D. of three independent experiments. The single asterisk
denote significant difference (p,0.05). The double asterisks denote
significant difference (p,0.01) (B) The cytotoxicity of cd T cells induced
by peptide BP3 to THP-1 infected with BCG. After sorting and culturing
the cd T cells from human subjects inoculated by BP3, MTT test was
used to evaluate the cytotoxicity activities of cd T cells to THP-1 cells
infected with BCG in vitro. Data are shown as the mean of three
independent experiments.
doi:10.1371/journal.pone.0018809.g005
Table 3. Blast Analysis of BP1, BP2 and BP3.
No. Reference Protein Species E value Matching part
BP1 ZP_06848846.1 stearoyl-CoA 9-desaturase Mycobacterium parascrofulaceum 22 RH-S-W- PHD
BP1 ZP_05225536.1 Fatty acid desaturase Mycobacterium intracellulare 22 RH-S-W- PHD
BP1 NP_959592.1 DesA1 Mycobacterium avium 22 RH-S-W- PHD
BP2 ZP_04748088.1 hypothetical protein MkanA1 Mycobacterium kansasii 34 LS- ELTLP
BP2 YP_890886.1 transcriptional regulator Mycobacterium smegmatis 34 L- KEL- LPL
BP2 YP_952896.1 aldehyde oxidase and xanthine dehydrogenase Mycobacterium vanbaalenii 34 L- KELT-LPL
BP3 ZP_06452924.1 oxidative stress response regulatory protein OXYS Mycobacterium tuberculosis K85 6e-04 HPETQDSDDVD
BP3 ZP_06435391.1 oxidative stress response regulatory protein OXYS Mycobacterium tuberculosis CPHL_A 6e-04 HPETQDSDDVD
BP3 ZP_05222720.1 LysR family transcriptional regulator Mycobacterium tuberculosis KZN 4207 6e-04 HPETQDSDDVD
doi:10.1371/journal.pone.0018809.t003
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39 (supplied in the kit).
Peptide synthesis and labeling
After in vitro screening and sequencing confirmation, 3
candidate peptides BP1, BP2 and BP3 were selected for further
analysis and were synthesized in the peptide synthesis facility of the
Academy of Military Medical Sciences, China. The purity of
synthesized peptides was more than 90% in HPLC analysis. Half
of the synthesized peptides were labeled with biotin at their N
terminal ends.
Protein expression and preparation of BCG soluble
extracts
Purified oxidative stress response regulatory protein (oxyS,
Rv0117) PCR fragments amplified from H37Rv genomic were
digested with KpnI and XhoI enzymes and linked into prokaryotic
expression plasmid pET30a. Freshly transformed E. coli BL21
(DE3) cells harboring plasmid pET30a-oxyS were cultured in
500 mL of LB medium containing kanamycin at 37uC. When the
cell density reached 0.8–1.0 (OD600), isopropyl-b-D-thiogalacto-
pyranoside (IPTG, Sigma) was added to a final concentration of
1 mM, and the bacteria were cultured for another 3 h at 37uC.
The culture was then harvested and centrifuged at 50006g for
15 min at 4uC. The inclusion body was dissolved in 8 M urea and
then purified with Amersham Biosciences HisTrap column. The
His-tagged protein molecular weight and purity were confirmed
by SDS-PAGE on 12% acrylamide gels and western blot. The
BCG bacteria were heat inactivated at 85uC for 20 min, and then
the bacteria were subjected to 5 h of sonification at room
temperature in a water bath sonicator. The extracts were then
spun at 130006g for 5 min and the supernatants were collected.
Binding of J.RT3-T3.5 transfectants to peptides and
proteins
The transfected cells were pre-incubated with 10 ng/mL
Phorbol Myristate Acetate (PMA) at room temperature for
30 min. After extensive washes with RPMI-1640, the cells were
plated into 24-well plates at 10
6 per well in the presence of 3
peptides, control peptide, OXYS protein, control protein or BCG
soluble extracts. The supernatants were harvested after 24 h and
the level of IL-2 was detected using the Human IL-2 ELISA Kit
(B.D.Company) according to the manufacturer’s instructions. The
binding of transfected cells to peptides was also detected via flow
cytometry. The cells were incubated with biotin-conjugated
peptide or control peptide and FITC-conjugated streptavidin
(eBioscience) was added, and the cells were incubated for 30 min
at 4uC. The cells were then analyzed by flow cytometry.
Figure 6. Binding and activating cd T cells by OXYS protein in vitro. (A) The expression of OXYS protein in E. coli was confirmed by 12% SDS-
PAGE. The molecular weight of the expressed OXYS is 44KD (B) The expression of OXYS protein was further confirmed by western blot using anti his-
tag antibody. (C) OXYS protein could stimulate the BCG cd T cells to produce IL-2 in a dose-dependent manner. LC3 protein, an autophagy detection
marker was used as the control protein. Data are shown as the mean of pg/ml6S.D. of three independent experiments. The double asterisks
represent significance difference (P,0.01). (D) OXYS protein could induce the expansion of cd T cells from human subjects inoculated with BCG.
Results are representative of three independent experiments. Panel 1 and panel 2 was the expansion percentage of cd T cells from human subjects
un-inoculated with BCG and inoculated with BCG induced by control protein, respectively. Panel 3 and panel 4 was the expansion percentage of cd T
cells from human subjects un-inoculated with BCG and inoculated with BCG induced by OXYS, respectively. (E) Detection of cd T cell proliferation by
CCK-8 assay. After the cd T cells expanded by protein were isolated by flow sorting, they (1610
5/100 ml) were inoculated into a 96-well plate
immobilized with different dosage of protein and incubated for 4 hours. CCK-8 reagent (10 ml) was added to each pore and continued to culture for
4 hours until the media turned yellow. The absorbance value (450 nm) of each pore was measured using a microplate reader. Data are shown as the
mean of three independent experiments.
doi:10.1371/journal.pone.0018809.g006
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un-vaccinated persons to peptides
Fresh PBMC from BCG vaccinated and un-vaccinated persons
in 24-well culture plates with RPMI 1640 medium were
immobilized with anti-pan cd TCR monoclonal antibody for 2
weeks to obtain enough amounts of cd T cells. The cells incubated
with biotin-conjugated peptide or control peptide and FITC-
conjugated streptavidin. The cells were analyzed by flow
cytometry.
Peptide/protein-immobilized amplification assay
PBMC from subjects vaccinated with BCG and un-vaccinated
subjects were immobilized with peptides or OXYS protein for the
amplification assay. The PBMC were cultured in RPMI 1640
medium with 10% FCS and IL-2 (200 U/mL) for 2 weeks and
then the percentage of cd T cells was measured by FACS analysis.
The positive cd T cells were isolated by flow sorting for further
functional experiments.
Determination of cd T cells proliferation
The proliferation of cd T cells was detected by the Cell
Counting Kit-8 (CCK-8) assay (KeyGEN). After the cd T cells
expanded by peptide and protein immobilization were isolated by
flow sorting, 1610
5/100 mL were inoculated into a 96-well plate,
immobilized with different dosages of peptide/protein, and
incubated for 4 h. CCK-8 reagent (10 mL) was added to each
well and culture was continued for 4 h until the media turned
yellow. The absorbance value at 450 nm of each well was
measured using a microplate reader (SpectraMax M5).
Cytokine production
After the cd T cells activated by BP3 peptide were sorted, the
production of cytokines IL-4, IL-10, TNF-a and IFN-c were
determined by ELISA according to the manufacturer’s instruc-
tions.
MTT cytotoxicity
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) colorimetric test was used to evaluate the cytotoxic
effects of cd T cells on THP-1 cells infected with BCG in vitro. The
BCG strain was grown in Middlebrook 7H9 liquid medium
(Invitrogen) with 10% albumin/dextrose-catalase (ADC) enrich-
ment media (sigma) supplemented with 0.2% glycerol. THP-1 cells
were infected with BCG strains at a multiplicity of infection (MOI)
of approximately 10 bacterial cells per macrophage. THP-1 cells
infected by BCG were used as target cells and seeded into 96-well
plates at 10
4 cells per well. The cd T effector cells were added to
each well with an appropriate ratio of effector cells and target cells.
After the effector cells and the target cells were incubated at 37uC
for 4 h, 15 mL of MTT solution (5 mg/mL) was added to each
well, and incubated at 37uC for an additional 4 h. The reaction
was stopped by the addition of 100 mL dimethyl sulfoxide to
dissolve the tetrazolium crystals. The plate was examined at 570/
630 nm on a microplate reader (SpectraMax M5) and the
percentage of specific lysis was calculated.
Bioinformatics analysis
Homologous analysis and sequence alignment were done using
BLAST (Basic Local Alignment Search Tool) programs to
determine matched protein of related peptides. In the NCBI
website http://www.ncbi.nlm.nih.gov/blast, the program of
protein BLAST was selected for bioinformatics analysis. The
amino acid sequences of BP1, BP2, and BP3 were input, the non-
redundant protein sequence (nr) was chosen in the database and
the organism was limited to Mycobacterium. Three matched proteins
with higher scores were listed. To demonstrate that the matched
protein was specific for Mycobacterium, we performed another blast
analysis in which the organism was limited in all species.
Statistical analysis
Statistical comparisons were performed using the Student’s t
test. A value of P,0.05 was considered statistically significant. In
BLAST analysis, the corresponding E-value for each score was
computed. The smaller the E-value, the greater the belief that the
aligned sequences are homologous.
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